Cargando…

MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer

PURPOSE: To analyze the role of six human epididymis protein 4 (HE4)‐related mitochondrial ribosomal proteins (MRPs) in ovarian cancer and selected MRPL15, which is most closely related to the tumorigenesis and prognosis of ovarian cancer, for further analyses. METHODS: Using STRING database and MCO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Haoya, Zou, Ruoyao, Li, Feifei, Liu, Jiyu, Luan, Nannan, Wang, Shengke, Zhu, Liancheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178508/ https://www.ncbi.nlm.nih.gov/pubmed/33934540 http://dx.doi.org/10.1002/cam4.3907

Ejemplares similares

A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma
por: Xu, Haoya, et al.
Publicado: (2021)

Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation
por: Zou, Ruoyao, et al.
Publicado: (2020)

Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
por: Zeng, Yangyang, et al.
Publicado: (2021)

MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer
por: Tao, Zuo, et al.
Publicado: (2020)

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer
por: Omichi, Chiaki, et al.
Publicado: (2016)

Methylation factor MRPL15 identified as a potential biological target in Alzheimer’s disease
por: Gao, Li, et al.
Publicado: (2021)

Clinical Nomograms for Predicting the Overall Survival and Cancer-specific Survival of patients with Ovarian Carcinosarcoma patients after Primary Surgery
por: Ren, Fang, et al.
Publicado: (2021)

MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma
por: Hu, Yangyang, et al.
Publicado: (2023)

In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma
por: Lvu, Wen, et al.
Publicado: (2020)

A Novel Clinical Nomogram for Predicting Cancer-Specific Survival in Adult Patients After Primary Surgery for Epithelial Ovarian Cancer: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database and External Validation in a Tertiary Center
por: Li, Xianli, et al.
Publicado: (2021)

Early inflammatory response in epithelial ovarian tumor cyst fluids
por: Kristjánsdóttir, Björg, et al.
Publicado: (2014)

Deficiency of the mitochondrial ribosomal subunit, MRPL50, causes autosomal recessive syndromic premature ovarian insufficiency
por: Bakhshalizadeh, Shabnam, et al.
Publicado: (2023)

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012)

Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characterization in ovarian cancer
por: Zhang, Jingjing, et al.
Publicado: (2022)

Intake of dietary flavonoids and risk of epithelial ovarian cancer(1)(2)(3)(4)
por: Cassidy, Aedín, et al.
Publicado: (2014)

Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea
por: Shin, Wonkyo, et al.
Publicado: (2021)

ING2 Controls Mitochondrial Respiration via Modulating MRPL12 Ubiquitination in Renal Tubular Epithelial Cells
por: Yang, Ying, et al.
Publicado: (2021)

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers
por: Sölétormos, György, et al.
Publicado: (2016)

Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer
por: Xu, Haoya, et al.
Publicado: (2023)

Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer
por: Wu, Jing, et al.
Publicado: (2020)

A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity
por: Yeo, Janet H. C., et al.
Publicado: (2015)

MRPL42 is activated by YY1 to promote lung adenocarcinoma progression
por: Jiang, Wei, et al.
Publicado: (2021)

MRPL12-ANT3 interaction involves in acute kidney injury via regulating MPTP of tubular epithelial cells
por: Ji, Xingzhao, et al.
Publicado: (2023)

Postoperative chemotherapy had no prognostic effect on early‐staged young ovarian cancer with unilateral resection
por: Zhang, Xiaofei, et al.
Publicado: (2018)

SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma
por: Guo, Tao, et al.
Publicado: (2022)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

A pilot in vivo study: potential ovarian cancer therapeutic by placental extracellular vesicles
por: Chen, Xinyue, et al.
Publicado: (2023)

Significance of lymphovascular space invasion in epithelial ovarian cancer
por: Matsuo, Koji, et al.
Publicado: (2012)

Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancer
por: Zhang, Qun-feng, et al.
Publicado: (2020)

Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma
por: Liang, Yuelong, et al.
Publicado: (2017)

The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
por: Sellers, Cortlandt M., et al.
Publicado: (2021)

CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
por: Yoshida, Kazumichi, et al.
Publicado: (2015)

LncRNA SRA mediates cell migration, invasion, and progression of ovarian cancer via NOTCH signaling and epithelial–mesenchymal transition
por: Kim, Lee Kyung, et al.
Publicado: (2021)

A nomogram to predict the cancer‐specific survival of stage II–IV Epithelial ovarian cancer after bulking surgery and chemotherapy
por: Zhao, Ling, et al.
Publicado: (2021)

Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma
por: Andersson, Charlotta, et al.
Publicado: (2014)

Mrpl10 and Tbp Are Suitable Reference Genes for Peripheral Nerve Crush Injury
por: Wang, Yaxian, et al.
Publicado: (2017)

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma
por: Wei, Dong, et al.
Publicado: (2023)

Methylation status and long‐fragment cell‐free DNA are prognostic biomarkers for gastric cancer
por: Ko, Kazuhide, et al.
Publicado: (2021)

The prognostic impact of programmed cell death 1 and its ligand and the correlation with epithelial‐mesenchymal transition in thymic carcinoma
por: Funaki, Soichiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uub8hlapup2i20bjban11hs1vd